- Home
- INSP vs CLDX Comparison
INSP vs CLDX Comparison
Compare INSP & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INSP | CLDX |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.1B |
| IPO Year | 2018 | 1995 |
Fundamental Metrics
Financial Performance| Metric | INSP | CLDX |
|---|---|---|
| Price | $53.32 | $32.02 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 10 |
| Target Price | ★ $94.00 | $46.60 |
| AVG Volume (30 Days) | 863.5K | ★ 1.1M |
| Earning Date | 05-04-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 179.43 | N/A |
| EPS | ★ 4.89 | N/A |
| Revenue | ★ $82,050,000.00 | $12,743,000.00 |
| Revenue This Year | $8.02 | $111.39 |
| Revenue Next Year | $8.11 | $235.85 |
| P/E Ratio | $11.28 | ★ N/A |
| Revenue Growth | 62.18 | ★ 87.78 |
| 52 Week Low | $48.30 | $17.87 |
| 52 Week High | $163.35 | $35.83 |
Technical Indicators
Market Signals| Indicator | INSP | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 43.15 | 47.65 |
| Support Level | $52.37 | $28.30 |
| Resistance Level | $60.15 | $34.52 |
| Average True Range (ATR) | 2.74 | 1.20 |
| MACD | 0.18 | -0.28 |
| Stochastic Oscillator | 22.99 | 8.85 |
Price Performance
Historical ComparisonAbout INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.